By Kevin Dunleavy
This summer, Regeneron warned investors not to expect sales of its COViD-19 antibody treatment to the U.S. in the third quarter. But a lucrative deal, signed in mid-September, and a quick supply helped push the company's third quarter revenue beyond expectations.
read more
By Conor Hale
The new Isomorphic Laboratories aims to deliver an “AI-first approach” for tackling biopharma research, with the goal of serving as a commercial partner to drugmakers.
read more
By Annalee Armstrong
Amgen already broke into the “undruggable” market with the approval of Lumakras, but that was just the tip of the iceberg for a pipeline strategy aimed at pursuing targets that were previously considered out-of-reach.
read more
By Eric Sagonowsky
Moderna has been biotech’s biggest growth story in 2021, but the company’s rate of expansion slowed considerably in recent months as shipping delays on its COVID-19 vaccine and a supply chain scale-up took a toll.
read more
By Anastassia Gliadkovskaya
The survey reached 600 data engineers, 100 of whom are managers. Nearly all of them reported experiencing burnout in their daily roles, and experts say healthcare is no exception.
read more
By Sharon Klahr Coey
Pharma marketers take note. Looking for higher click engagement? Run ads Monday and Tuesday. If higher conversion engagement is the goal, though, then it’s Tuesday and Saturday. In terms of the best time—the peak is around 3 p.m. for click engagement and 9 p.m. for conversion, all according to advertising software company Viant Technology,
read more
By Conor Hale
Outside of pandemic-related diagnostic sales, Siemens posted growth of 11.8% compared to the year before, driven by expansions in its core testing, imaging and advanced therapy segments.
read more
By Nick Paul Taylor
Sangamo Therapeutics has posted clinical data on a therapy it hopes will shake up the Fabry disease market. The gene therapy showed encouraging safety and efficacy signs in the small study, prompting Sangamo to start preparations for a phase 3 clinical trial.
read more
By Andrea Park
Altogether, the entire multipart system is designed to be broadly accessible and easily updated and expanded by labs across networks and around the world.
read more
By Ben Adams
As Bayer looks to ramp up its R&D work in the gene therapy space amid a host of biotech tie-ups, the German pharma is tapping Christoph Koenen as its new global head of clinical development and operations in its R&D unit.
read more
By Anastassia Gliadkovskaya
The American Medical Informatics Association is hosting its 2021 Annual Symposium. During its virtual day last week, researchers presented multiple studies on how technology can or does affect the daily lives of patients and providers.
read more
By Andrea Park
Several lucky startups developing new technologies to transform the medical field are about to get quite a bit richer—$740 million richer, to be exact.
read more
